Document is current
Any future updates will be listed below
-
Authors
Matheu, Gabriel https://orcid.org/0009-0003-6640-4243
Bermejo-Peréz, María José https://orcid.org/0000-0002-6293-850X
Escudero-García, Nuria https://orcid.org/0009-0006-6203-5681
Garcia-Duran, Carmen
Gatius-Caldero, Sonia https://orcid.org/0000-0002-1636-6010
Guerra-Alía, Eva https://orcid.org/0009-0002-5556-2337
López-Agullo, Susana https://orcid.org/0009-0008-2364-3427
Romero, Ignacio https://orcid.org/0000-0001-8622-618X
Yange, Geanella https://orcid.org/0009-0004-9955-2215
Barretina-Ginesta, Maria-Pilar https://orcid.org/0000-0003-0074-6614
-
Funding
Funding for this research was provided by:
GlaxoSmithKline foundation
AstraZeneca España
AbbVie Deutschland
- License Information
-
More Information
Article History
Received: 8 March 2026
Accepted: 11 March 2026
First Online: 12 May 2026
Declarations
:
: The authors declare that, when writing and revising the text, they did not know the names of the pharmaceutical companies that provided financial support for this project, so this support has not influenced the content of this article.
: The study has been performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments. This article does not contain any studies with human participants or animals performed by any of the authors.
